Document ID: chunk:federal_register_of_legislation:F2024L01341:front:0:p2
Version: federal_register_of_legislation:F2024L01341
Segment Type: other
Provision Reference: 
Character Range: 2952–6224

under the VEA, or members under the MRCA.
Note: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary.
 1.                Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, retrocalcaneal heel bursitis or death from retrocalcaneal heel bursitis is connected with the circumstances of a person's relevant service:
 1.           Running or jogging an average of at least 60 kilometres per week for the 4 weeks before clinical onset or clinical worsening;
 2.           undertaking weight bearing exercise involving repeated activity of the ankle joint on the affected side for:
         1.           a minimum intensity of 5 METS; and
         2.           for at least 6 hours per week; and
         3.           for at least the 4 weeks before clinical onset or clinical worsening;
Note 1: Examples of weight bearing exercise involving repeated activity of the ankle joint at a minimum intensity of 5 METS include marching, playing basketball, football, volleyball, and track and field (especially those activities that involve jumping).
Note 2: MET (metabolic equivalent) is a unit of measure of the level of physical capability of the cardiorespiratory system. For example, 1 MET = cardiorespiratory effort associated with a person sitting, 3-4 METs = cardiorespiratory effort associated with a person walking at average walking pace (5 km/h) or light gardening.
 1.           having one of the following systemic arthritic diseases at the time of clinical onset or clinical worsening:
         1.           ankylosing spondylitis;
         2.           Behcet syndrome;
         3.           enteropathic spondyloarthropathy (arthritis associated with inflammatory bowel disease);
         4.           gout;
         5.           pseudogout (calcium pyrophosphate dihydrate) or crystal-induced arthropathy from the deposition of calcium hydroxyapatite or calcium oxalate;
         6.            psoriatic arthropathy;
         7.           reactive arthritis;
         8.           rheumatoid arthritis; or
         9.             undifferentiated spondyloarthropathy;
 2.           having a bacterial infection of the affected retrocalcaneal bursa at the time of clinical onset or clinical worsening;
 3.           inability to obtain appropriate clinical management for retrocalcaneal heel bursitis before clinical worsening.
 1.            Relationship to service
         1.           The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.
         2.           The clinical worsening aspects of factors set out in section 9 apply only to material contribution to, or aggravation of, retrocalcaneal heel bursitis where the person's retrocalcaneal heel bursitis was suffered or contracted before or during (but did not arise out of) the person's relevant service.
 2.            Factors referring to an injury or disease covered by another Statement of Principles
In this Statement of Principles:
 1.           if a factor referred to in section 9 applies in relation to a person; and
 2.           that factor refers to an injury or disease in respect of which a Statement of Principles